Navigation Links
Measuring disseminated cancer cells in bone marrow - valuable tool for detecting early breast cancer metastasis

Stephan Braun and colleagues have reported in the New England Journal of Medicine, that the detection of disseminated tumor cells in bone marrow samples is a more reliable determinant of metastasis and patient survival. //

The disease progression is measured by taking biopsy samples from breast cancer patients and the level of lymph node metastases is measured to determine the disease prognosis. But research results as shown that 30% of patients with lymph node negative status still develop metastatic disease. A new approach to overcome this has been found in which the detection of micrometases in bone marrow is detected which can be a better clinical tool for early detection of disease metastasis.

Breast tumor cells frequently bypass the lymph nodes and disseminate directly through the blood to distant organs. This Hematogenous dissemination of cancer cells has been shown to be an early event in tumor progression. Analysis of data from 9 studies involving 4,703 patients with stage I, II or III breast cancer, the authors evaluated the association between detection of bone marrow micrometastases and patient outcome over a 10 year period.

The study compared the effects of different factors, such as tumor size, grade, bone marrow metastasis, lymph node metastasis and hormone receptor expression , and revealed that the presence of micrometases in bone marrow were the best predictors of outcome within the first 5 years after diagnosis. Bone marrow micrometastases were detected in over 30% of patients and these patients were found to develop larger tumors with a higher histological grade that more frequently metastasized to other organs.

Patients with bone marrow micrometastases were more likely to die of the disease, even among patients that received adjuvant therapy. In patients with very small tumors without lymph node metastases, and who therefore did not receive adjuvant therapy, the presence of bone marrow micrometastase s was also associated with shorter survival times. This procedure of detecting bone marrow micrometastases could be a complementary approach to lymph node biopsies in determining which patients should receive adjuvant therapy.

Source: Nature Review Cancer.
'"/>




Related medicine news :

1. Measuring Death Risk in COPD Patients
2. Measuring Exercise Capacity To Predict Heart Disease
3. A Novel Method For Measuring Interstitial Fluid Pressure In Cancer Tissues
4. Measuring Urinary Protein Helps In Detecting Recurrent Bladder Cancer
5. New Method For Measuring Dyskinesia In Parkinsons Being Developed
6. Measuring the Quantity of Information Passed on From the Eye to the Brain
7. Measuring Calcium Intake Help to Identify Osteoporosis in Prostate Cancer Patient
8. Vitamin B12 can help in detecting cancers
9. Want skin cancer? Please have a cigarette
10. New hope for cancer victims – will vaccine cure the deadly bug
11. Clintons new problem - Is the outgoing American president suffering from skin cancer?
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/9/2018)... ... November 09, 2018 , ... ... has awarded microbiome research support in study design, planning, sample collection, and analysis ... Sospedra, PhD, to study the effects of a nutritional intervention on the sports ...
(Date:11/9/2018)... ... November 08, 2018 , ... ... HPH Hospice and LifePath Hospice ) announced today Dean H. ... December 3, 2018. Forman will report directly to President and Chief Executive Officer ...
(Date:11/8/2018)... ... November 08, 2018 , ... How ... different media sources could impact how they view advertising and earned media in ... Connections, Inc. will release results of the tenth annual study of the media ...
(Date:11/8/2018)... (PRWEB) , ... November 08, 2018 , ... Dutch Bros ... of Breast Cancer Awareness Month. For each custom “Be Aware” mug sold in October, ... “We are so proud of the support our customers showed for these amazing organizations,” ...
(Date:11/8/2018)... ... November 08, 2018 , ... Porchlight VNA/Home Care ... enhance disease management for high risk patients. , Porchlight VNA/Home Care plans to ... for hospital readmissions and emergency department visits, primarily patients with CHF and COPD. ...
Breaking Medicine News(10 mins):
(Date:11/9/2018)... ... November 09, 2018 , ... OnlineMasters.com, an industry-leading ... Psychology Programs for 2019. They have identified the top programs in the nation ... and graduate outcomes. , Leveraging an exclusive data set comprised of interviews and ...
(Date:11/9/2018)... ... November 09, 2018 , ... One in seven Americans ... that makes Thanksgiving food drives urgently important. Yet, despite good intentions, people often ... donations. Colorado-based nonprofit Heaven On Earth NOW has launched a “Think Before You ...
(Date:11/9/2018)... ... ... Triple W, an innovator of connected health devices, today announced that it has ... the first health tech wearable device for incontinence that monitors how full your bladder ... was made during CES Unveiled New York, an invite-only tech event bringing together top ...
Breaking Medicine Technology: